Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DUT | P33316 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20088142 | 0.85 | DUT (0.41) | DUT | |
| SCHEMBL26510570 | 0.85 | DUT (0.41) | DUT | |
| SCHEMBL11580466 | 0.85 | DUT (0.42) | DUT | |
| SCHEMBL1317211 | 0.84 | ADRB2 (0.42) | DUT | |
| Ammonia Solution, Strong SCHEMBL6287147 | 0.82 | ADRB2 (0.40) | DUT | |
| SCHEMBL622169 | 0.82 | DUT (0.39) | DUT | |
| SCHEMBL8072599 | 0.80 | DUT (0.38) | DUT | |
| SCHEMBL9671669 | 0.80 | DUT (0.38) | DUT | |
| SCHEMBL13645501 | 0.80 | DUT (0.38) | DUT | |
| SCHEMBL31039441 | 0.80 | DUT (0.38) | DUT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 302 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220301862-A1 | MONOALKOXYSILANES AND DENSE ORGANOSILICA FILMS MADE THEREFROM | VERSUM MATERIALS US, LLC (US) | 2022-09-22 | — | — | US | claimed |
| EP-4018013-A1 | MONOALKOXYSILANES AND DENSE ORGANOSILICA FILMS MADE THEREFROM | Versum Materials US, LLC (US) | 2022-06-29 | — | — | EP | claimed |
| CN-114616652-A | Monoalkoxysilanes and dense organosilica films prepared therefrom | 弗萨姆材料美国有限责任公司 | 2022-06-10 | — | — | CN | claimed |
| WO-2021050659-A1 | MONOALKOXYSILANES AND DENSE ORGANOSILICA FILMS MADE THEREFROM | VERSUM MATERIALS US, LLC (US) | 2021-03-18 | — | — | WO | claimed |
| US-7335712-B2 | Process of producing a siloxy-functionalized polymer | BRIDGESTONE CORPORATION (JP) | 2008-02-26 | — | — | US | claimed |
| WO-2000050478-A1 | NOVEL FORMULATIONS OF ALKYLLITHIUMS WITH IMPROVED THERMAL STABILITY, PROCESSES TO PRODUCE THESE FORMULATIONS AND PROCESSES FOR USING THE SAME TO IMPROVE STABILITY OF LIVING POLYMER CHAIN ENDS | FMC CORPORATION (US) | 2000-08-31 | — | — | WO | claimed |
| EP-1023333-A1 | PROCESSES FOR IMPROVING STABILITY OF LIVING POLYMERIZATION CHAIN ENDS | FMC CORPORATION (US) | 2000-08-02 | — | — | EP | claimed |
| WO-1999012979-A1 | PROCESSES FOR IMPROVING STABILITY OF LIVING POLYMERIZATION CHAIN ENDS | FMC CORPORATION (US) | 1999-03-18 | — | — | WO | claimed |
| US-12297208-B2 | Small molecule inhibitors of KRAS G12C mutant | MERCK SHARP & DOHME LLC (US) | 2025-05-13 | — | — | US | disclosed |
| EP-3080167-B1 | METHOD FOR PRODUCING POLYMERIC COMPOSITIONS INCLUDING FUNCTIONALIZED POLYMERS | FIRESTONE POLYMERS LLC (US) | 2024-12-04 | — | — | EP | disclosed |
| US-20240336717-A1 | FUNCTIONALIZED POLYMERS HAVING THERMORESPONSIVE BEHAVIOR | BRIDGESTONE AMERICAS TIRE OPERATIONS, LLC | 2024-10-10 | — | — | US | disclosed |
| US-12054573-B2 | Functionalized polymers having thermoresponsive behavior | BRIDGESTONE CORPORATION (JP) | 2024-08-06 | — | — | US | disclosed |
| EP-3052531-B1 | POLYMERS FUNCTIONALIZED WITH IMINE COMPOUNDS CONTAINING A CYANO GROUP | BRIDGESTONE CORP (JP) | 2024-07-24 | — | — | EP | disclosed |
| US-20240218116-A1 | POLYOLEFIN MIMIC POLYESTER COPOLYMERS | SABIC GLOBAL TECHNOLOGIES BV (NL) | 2024-07-04 | — | — | US | disclosed |
| EP-1023333-A1 | PROCESSES FOR IMPROVING STABILITY OF LIVING POLYMERIZATION CHAIN ENDS | FMC CORPORATION (US) | 2000-08-02 | — | — | EP | disclosed |
| WO-1999012979-A1 | PROCESSES FOR IMPROVING STABILITY OF LIVING POLYMERIZATION CHAIN ENDS | FMC CORPORATION (US) | 1999-03-18 | — | — | WO | disclosed |
| EP-0442654-A2 | Heterocyclic compounds | ZENECA LIMITED (GB) | 1991-08-21 | — | — | EP | disclosed |
| EP-0134695-B1 | PHOTOGRAPHIC ELEMENT CONTAINING A 4-HYDROXYALKYL-SUBSTITUTED 1-PHENYL-3-PYRAZOLIDINONE ELECTRON TRANSFER AGENT | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1987-09-30 | — | — | EP | disclosed |
| EP-0232017-A1 | Antimicrobial N-acyl-2-azetidinones | THE UPJOHN COMPANY (US) | 1987-08-12 | — | — | EP | disclosed |
| US-4395418-A | 6-HYDROXYETHYL SUBSTITUTED ANTIBIOTICS | SANKYO COMPANY LIMITED (JP) | 1983-07-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12297208-B2 | Small molecule inhibitors of KRAS G12C mutant | KRAS, NRAS, HRAS | DUT 3905/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.